U.S. Markets close in 30 mins

Editas Medicine, Inc. (EDIT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
32.17+1.90 (+6.26%)
As of 3:28PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close30.27
Open30.40
Bid31.69 x 1400
Ask31.72 x 1100
Day's Range30.40 - 32.19
52 Week Range14.01 - 39.96
Volume457,987
Avg. Volume896,326
Market Cap2.003B
Beta (5Y Monthly)2.08
PE Ratio (TTM)N/A
EPS (TTM)-2.49
Earnings DateNov 10, 2020 - Nov 16, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est41.75
  • Benzinga

    Understanding Editas Medicine's Unusual Options Activity

    Editas Medicine (NASDAQ: EDIT) shares experienced unusual options activity on Wednesday. The stock price moved down to $31.74 following the option alert. * Sentiment: BEARISH * Option Type: TRADE * Trade Type: CALL * Expiration Date: 2020-11-20 * Strike Price: $35.00 * Volume: 2009 * Open Interest: 7993Three Indications Of Unusual Options Activity Extraordinarily large volume (compared to historical averages) is one indication of unusual options market activity. Volume refers to the total number of contracts traded over a given time period when discussing options market activity. The number of unsettled contracts that have been traded, but not yet closed, is called open interest. These contracts are not yet closed because a buyer has not purchased the contract, or a seller has not sold it.The trading of a contract with an expiration date in the distant future is another sign of unusual activity. Generally, additional time until a contract expires increases the potential for it to reach its strike price and grow its time value. Time value is important in this context because it represents the difference between the strike price and the value of the underlying asset.Contracts with a strike price far from the underlying price are also considered unusual because they are defined as being "out of the money". This occurs when the underlying price is under the strike price on a call option, or above the strike price on a put option. These trades are made because the underlying asset value is expected to change dramatically in the future, and the buyer or seller can take advantage of a greater profit margin.Understanding Sentiment Options are "bullish" when a call is purchased at/near ask price or a put is sold at/near bid price. Options are "bearish" when a call is sold at/near bid price or a put is bought at/near ask price.These observations are made without knowing the investor's true intent by purchasing these options contracts. The activity is suggestive of these strategies, but an observer cannot be sure if a bettor is playing the contract outright or if the options bettor is hedging a large underlying position in common stock. For the latter case, bullish options activity may be less meaningful than the exposure a large investor has on their short position in common stock.Using These Options Strategies Unusual options activity is an advantageous strategy that may greatly reward an investor if they are highly skilled, but for the less experienced trader, it should remain as another tool to make an educated investment decision while taking other observations into account.For more information to understand options alerts, visit https://pro.benzinga.help/en/articles/1769505-how-do-i-understand-options-alertsSee more from Benzinga * Options Trades For This Crazy Market: Get Benzinga Options to Follow High-Conviction Trade Ideas * P/E Ratio Insights for Knight-Swift * Understanding Keurig Dr Pepper's Unusual Options Activity(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • The Zacks Analyst Blog Highlights: Emergent BioSolutions, Vertex Pharmaceuticals, Editas Medicine, Cellectis and Thermo Fisher
    Zacks

    The Zacks Analyst Blog Highlights: Emergent BioSolutions, Vertex Pharmaceuticals, Editas Medicine, Cellectis and Thermo Fisher

    The Zacks Analyst Blog Highlights: Emergent BioSolutions, Vertex Pharmaceuticals, Editas Medicine, Cellectis and Thermo Fisher

  • Booming Gene Editing Market to Pep Up These 5 Biotech Stocks
    Zacks

    Booming Gene Editing Market to Pep Up These 5 Biotech Stocks

    Advancements in gene editing have boosted the biotech space, putting the spotlight on five stocks that can make the most.